FDA issues generic guidance on GSK’s top-selling asthma drug, Advair – Philly.com (blog)


Yahoo!7 News

FDA issues generic guidance on GSK's top-selling asthma drug, Advair
Philly.com (blog)
PhillyPharma. FDA issues generic guidance on GSK's top-selling asthma drug, Advair. GlaxoSmithKline's top-selling drug by far is the asthma medication Advair, which accounts for about 20 percent of company revenue. Generic competition got a bit closer
GlaxoSmithKline Shares Fall After Advair SetbackWall Street Journal
Glaxo Declines as FDA Clears Path for Advair RivalsBloomberg
New FDA guidance threatens GlaxoSmithKline's AdvairFiercePharma
euronews
all 13 news articles »

View full post on asthma – Google News

GlaxoSmithKline’s asthma med among top-selling drugs in U.S. – Triangle Business Journal (blog)

GlaxoSmithKline's asthma med among top-selling drugs in U.S.
Triangle Business Journal (blog)
The British drug company, which has its North American headquarters in Research Triangle Park, comes in fifth with asthma medicine Advair Diskus. The rest of the top five: Otsuka Pharmaceuticals' Abilify. AstraZeneca Pharmaceuticals' (NYSE: AZN) Nexium

View full post on asthma – Google News